Adaptin Bio reported net income of -$1.21M for the quarter ended Jun 2026. This income statement covers 13 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2022 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | |||||||||||||
| Research & DevelopmentR&D | 0.20M | 0.69M | 0.68M | 0.26M | 0.06M | 0.34M | 0.78M | 0.59M | 0.17M | 0.14M | |||
| Selling, General & AdministrativeSG&A | 0.04M | 0.03M | 0.10M | 0.08M | 0.31M | 0.25M | 0.79M | 1.18M | 0.90M | 0.77M | 0.98M | 1.06M | |
| Restructuring CostsRestructuring | 0.18M | ||||||||||||
| Other Operating ExpensesOther Opex | -0.18M | ||||||||||||
| Operating ExpensesOpex | 0.04M | 0.03M | 0.30M | 0.77M | 0.99M | 0.51M | 0.85M | 1.52M | 1.68M | 1.37M | 1.14M | 1.20M | |
| Operating IncomeOp. Inc | -0.04M | -0.03M | -0.30M | -0.77M | -0.99M | -0.51M | -0.85M | -1.52M | -1.68M | -1.37M | -1.14M | -1.20M | |
| EBIT | -0.04M | -0.03M | -0.30M | -0.77M | -0.99M | -0.51M | -0.85M | -1.52M | -1.68M | -1.37M | -1.14M | -1.20M | |
| Non-operating items | |||||||||||||
| Non Operating Interest Expenses | 0.04M | 0.05M | 0.11M | 0.15M | 0.07M | 0.00M | 0.00M | ||||||
| Other Non Operating IncomeOther Non Op Inc. | -133.00 | -0.00M | -0.01M | -0.19M | 0.33M | 0.33M | |||||||
| Non Operating IncomeNon Op. Inc. | -0.04M | -0.05M | -0.11M | -0.35M | 0.25M | -0.00M | -0.00M | ||||||
| Net income details | |||||||||||||
| EBT | -0.04M | -0.03M | -0.34M | -0.82M | -1.11M | -0.86M | -0.60M | -1.52M | -1.68M | -1.40M | -1.15M | -1.21M | |
| Profit After TaxPAT | -0.04M | -0.03M | -0.34M | -0.82M | -1.11M | -0.86M | -0.60M | -1.52M | -1.68M | -1.37M | -1.15M | -1.21M | |
| Income from Continuing OperationsIncome (Continuing) | -0.04M | -0.03M | -0.34M | -0.82M | -1.11M | -0.86M | -0.60M | -1.52M | -1.68M | -1.40M | -1.15M | -1.21M | |
| Consolidated Net IncomeConsol Net Inc. | -0.04M | -0.03M | -0.34M | -0.82M | -1.11M | -0.86M | -0.60M | -1.52M | -1.68M | -1.40M | -1.15M | -1.21M | |
| Income towards Parent CompanyParent Net Inc | -0.04M | -0.03M | -0.34M | -0.82M | -1.11M | -0.86M | -0.60M | -1.52M | -1.68M | -1.40M | -1.15M | -1.21M | |
| Net Income towards Common StockholdersNet Income | -0.04M | -0.03M | -0.34M | -0.82M | -1.11M | -0.86M | -0.60M | -1.52M | -1.68M | -1.40M | -1.15M | -1.21M | |
| Additional items | |||||||||||||
| EPS (Basic) | -0.01 | -0.01 | -0.07 | -0.16 | -0.22 | -0.17 | -0.10 | -0.18 | -0.20 | -0.18 | -0.13 | -0.14 | |
| EPS (Diluted) | -0.01 | -0.01 | -0.07 | -0.16 | -0.22 | -0.17 | -0.10 | -0.18 | -0.20 | -0.18 | -0.13 | -0.14 | |
| Shares Outstanding | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.83M | 8.45M | 8.46M | 7.81M | 8.70M | 8.85M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.83M | 8.45M | 8.46M | 7.81M | 8.70M | 8.85M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.83M | 8.46M | 8.46M | 8.66M | 8.79M | 9.05M |
| EBITDA | -0.04M | -0.03M | -0.30M | -0.77M | -0.99M | -0.51M | -0.85M | -1.52M | -1.68M | -1.37M | -1.14M | -1.20M | |
| Interest ExpensesInt Expense | 0.04M | 0.05M | 0.11M | 0.15M | 0.07M | 0.00M | 0.00M |